Lee Pharmaceuticals Inc

Company Profile

Lee Pharmaceuticals Inc had its IPO on under the ticker symbol LPHM.

The company operates in the Technology sector and Software-Application industry. Lee Pharmaceuticals Inc has a staff strength of 1 employees.

Stock update

Shares of Lee Pharmaceuticals Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.05, and closed at $0.05.

This is a -5.85% slip from the previous day's closing price.

A total volume of 700 shares were traded at the close of the day’s session.

In the last one week, shares of Lee Pharmaceuticals Inc have slipped by -16.69%.

Lee Pharmaceuticals Inc's Key Ratios

Lee Pharmaceuticals Inc has a market cap of $273201, indicating a price to book ratio of 0 and a price to sales ratio of 0.0311.

In the last 12-months Lee Pharmaceuticals Inc’s revenue was $8.92 million with a gross profit of $3.03 million and an EBITDA of $-194000. The EBITDA ratio measures Lee Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Lee Pharmaceuticals Inc’s operating margin was 0% while its return on assets stood at -1670.94% with a return of equity of 0%.

In Q2, Lee Pharmaceuticals Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 30%.

Lee Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.12 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lee Pharmaceuticals Inc’s profitability.

Lee Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0.8202 and a EV to EBITDA ratio of -22.2334. Its price to sales ratio in the trailing 12-months stood at 0.0311.

Lee Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0

Total Liabilities

$555295.00

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Lee Pharmaceuticals Inc ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

Lee Pharmaceuticals Inc ended 2024 with $0 in deferred long-term liabilities, $555295.00 in other current liabilities, 5162.00 in common stock, $-5317095.00 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Lee Pharmaceuticals Inc’s total current assets stands at $13168.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Lee Pharmaceuticals Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Lee Pharmaceuticals Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.05

52-Week High

$0.4

52-Week Low

$0.012

Analyst Target Price

$

Lee Pharmaceuticals Inc stock is currently trading at $0.05 per share. It touched a 52-week high of $0.4 and a 52-week low of $0.4. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.08 and 200-day moving average was $0.14 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.